But I believe CYP doesn't require 3D manufacturing like bone marrow derived technologies, because of the IPSC starting material, which is uniform, consistent and infinitely expandable without facing the issues of cell senescence. I believe 3D is required for bone marrow derived cells because of the senescence issues related to batch to batch inconsistencies? CYP surpasses the need for 3D cell scaffolding, does it not? Please correct me if I'm wrong.
CYP Price at posting:
14.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)